Investigation of Markedly Elevated Liver Enzymes With Serendipitous Underlying Wilson’s Disease With Chronic Alcohol Abuse
Khiet T Nguyen, Dat D Nguyen, Leidhy Montecinos, Pwint P Hlaing, Samridhi Khatri

TL;DR
A patient with a history of heavy alcohol use and high liver enzymes was found to also have Wilson's disease, highlighting the need for broad diagnostic approaches in similar cases.
Contribution
This case highlights Wilson's disease as a potentially masked cause of acute hepatitis in patients with overlapping risk factors like alcohol abuse.
Findings
A patient with chronic alcohol abuse and elevated liver enzymes was found to have Wilson's disease.
Wilson's disease can present alongside or mask other causes of acute hepatitis.
Clinicians should consider Wilson's disease in a broad differential diagnosis for acute hepatitis.
Abstract
Acute hepatitis can result from a wide variety of noninfectious causes that include, but are not limited to, drugs (drug-induced hepatitis), alcohol (alcoholic hepatitis), immunologic (autoimmune hepatitis, primary biliary cholangitis), or as a result of indirect insult secondary to biliary tract dysfunction (cholestatic hepatitis), pregnancy-related liver dysfunction, shock, or metastatic disease. In clinical settings, these causes are not uncommon to overlap with each other or are masked by obviously visible causes in medical history. We reported our scenario of a patient who has a heavy history of alcohol use and presented with alcohol withdrawal symptoms and a marked elevation of liver enzymes. Interestingly, further investigations suggested Wilson's disease could be an underlying culprit of acute hepatitis in this patient. This case again emphasized that Wilson's disease can be…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Laboratory Parameters | Patient’s Value | Reference Range |
| AST | >2400 mg/dL | 7-52 U/L |
| ALT | 2109 mg/dL | 13-39 U/L |
| ALP | 103 mg/dL | 34-104 U/L |
| Total bilirubin | 1.4 mg/dL | 0.3-1.0 mg/dL |
| Direct bilirubin | 0.66 mg/dL | 0.03-0.18 mg/dL |
| PT/aPTT/INR | 19/32/1.58 | 9.8-13.4 sec/24.9-35.9 sec/0.85-1.15 |
| GGT | >1200 mg/dL | 9-64 U/L |
| Serum alcohol | 280 mg/dL | <10 mg/dL |
| NH3 | 106 µmol/L | 16-53 µmol/L |
| Lipase | 150 (H) U/L | 11-83 U/L |
| WBC | 4.9x103/µL | 4.5-11.0x103/µL |
| RBC | 3.44(L)x106/µL | 3.8-5.3x106/µL |
| HBG | 12.4 g/dL | 11.0-15.0 g/dL |
| HCT | 34.8% (L) | 35%-46% |
| MCV | 101.2 (H) fL | 80-100 fL |
| MCH | 36.2 (H) pg | 26.0-33.0 pg |
| MCHC | 35.7 g/dL | 30.5-36.0 g/dL |
| RDW | 13.6% | 11.5%-15.1% |
| MPV | 6.5 (L) fL | NA |
| Platelets | 407 (H)x103/µL | 130-400x103/µL |
| Laboratory Parameters | Patient’s Value | Reference Range |
| Ceruloplasmin | 9.6 mg/dL | 19.0-39.0 mg/dL |
| Ferritin | 2331 mg/dL | 11.00-306.80 ng/mL |
| Hereditary hemochromatosis DNA screening | Undetected | NA |
| Transferrin saturation | 99% | NA |
| Anti-smooth muscle Ab | Negative | 0-19 Units |
| Liver kidney microsomal Ab | Negative | 0.0-20.0 Units |
| Hepatitis A | Non-reactive | NA |
| Hepatitis B | Non-reactive | NA |
| Hepatitis C | Non-reactive | NA |
| Hepatitis E | Non-reactive | NA |
| CMV | IgM negative/IGG positive | NA |
| EBV | IgM/IgG negative | NA |
| ANA | Negative | NA |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsTrace Elements in Health · Metabolism and Genetic Disorders · Gout, Hyperuricemia, Uric Acid
Introduction
Wilson's disease is an autosomal recessive inherited disorder of copper metabolism with a prevalence of approximately 1:30,000 [1]. Clinical scenarios for Wilson's disease could vary from acute hepatitis failure to chronic hepatitis to cirrhosis [2]. The diagnosis of Willson's disease, which causes elevated transaminase, could be challenging when other apparent causes, such as alcohol abuse, hepatitis virus infection, or an iron profile favored for hemochromatosis, could masquerade as the actual cause. Due to the non-specific symptoms of Wilson's disease during its early stages, should physicians consider Wilson's disease as something that must be investigated at a young age in order to warrant early treatment or liver transplant screening criteria?
We report a case of a 26-year-old female who heavily consumed alcohol daily for more than eight years and initially presented severely elevated transaminitis with alcohol withdrawal symptoms. Subsequent examination indicated that Wilson's disease could be the underlying cause of this scenario.
Case presentation
A 26-year-old female with a history of chronic alcohol abuse, consuming one bottle of vodka and half a liter of whisky daily since the age of 18, presented to the emergency department requesting alcohol detox due to poor appetite and weakness. The patient has been experiencing not feeling well and showed some tremors with nausea and vomiting, generalized body aches, and general weakness. The patient consumed alcohol the day before admission in an attempt to control the withdrawal symptoms.
Two weeks before this admission, the patient completed 10 days of alcohol detox in another hospital. During the physical exam, the patient was alert, awake, and oriented. The physical examination was unremarkable, and there was mild epigastric tenderness. The Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) score of the patient is 8, which indicates minimal to mild withdrawal.
The family history is remarkable for liver diseases, but it is unclear in detail.
The blood test showed severely elevated liver enzymes with aspartate aminotransferase (AST) level of >2400 mg/dL, alanine transaminase (ALT) of 2109 mg/dL, international normalized ratio (INR) of 1.58, alkaline phosphatase (ALP) of 103 mg/dL, total bilirubin level of 1.4 mg/dL, direct bilirubin of 0.66 mg/dL, and fibrinogen of 103 mg/dL. Serum alcohol was 280 mg/dL. The results are described in Table 1.
The CT scan of the abdomen was unremarkable except for a diffuse thickening of the descending colon.
Although the patient has a significant medical history related to alcohol use, other causes were investigated for severe acute hepatitis, including hepatitis viruses, hemochromatosis, autoimmune diseases, and Wilson's disease. The results showed a ferritin level of 2331 mg/dL, transferrin level of 99%, negative smooth muscle antibody, negative hepatitis A, B, and C, triglyceride level of 950 mg/dL, alpha 1 antitrypsin level of 114 mg/dL, ceruloplasmin level of 9.6 mg/dL, negative antinuclear antibodies (ANA), GGT of >1200 mg/dL, negative cytomegalovirus (CMV) IgM, positive IGG, and negative Epstein-Barr virus (EBV) IgM/IgG. Additionally, the results showed that the patient is negative for liver kidney microsomal Ab, mitochondrial Ab, and hereditary hemochromatosis DNA screening. The detailed lab results are described in Table 2 below.
The patient was managed with N-acetylcysteine (NAC) infusion protocol for non-acetaminophen hepatotoxicity with supportive care.
The ceruloplasmin result was measured at 9.6 mg/dL, indicating a strong likelihood of Wilson's disease. The patient left against medical advice after being admitted for one day in the hospital.
Other workups failed to establish a conclusive diagnosis of Wilson's disease. Subsequently, the patient was contacted by phone to convey the recommendations for further investigation of Wilson's disease.
Discussion
Wilson's disease is a rare condition with abnormalities in copper metabolism that manifest commonly in liver and neurological functions. The range of clinical illustrations of Wilson's disease varies from fulminant hepatic failure with hemolytic anemia to chronic hepatic disease. In our case, although this patient had an extensive history of alcohol abuse since being a teenager, a markedly elevated transaminase of > 15 times the upper limit warrants further investigation for overlap of underlying conditions [3,4].
Alcoholic hepatitis commonly presents with mildly elevated ALT levels of <300 UI/L and rarely >500 IU/L. Additionally, the AST:ALT ratio is typically >2. In situations where the ALT level is >500 IU/L, even if the AST:ALT ratio is >2, other etiologies should be explored [4]. Hepatitis viruses, including HAV, HBV, HCV, HEV, EBV, and CMV, were excluded from the results. Autoimmune diseases were investigated with extensive autoimmune markers, but no evidence of these diseases was found.
In addition to that, in our case, a markedly increasing ferritin level and iron saturation of >99% would preliminarily suggest hemochromatosis. However, this was later disproven through a negative HFE gene mutation. This phenomenon can be explained by the Coombs-negative hemolysis of Wilson’s disease outburn or in fulminate hepatic failure with an acute inflammatory phase. There are several reports about iron overload in Wilson’s disease, which leads to potential secondary hemochromatosis [5].
Interestingly, a remarkably elevated triglyceride level of >950 mg/dL in this case raises the question about lipid metabolism or, more specifically, triglyceride altered in Wilson's disease itself or the result of acute hepatic injury. Further investigation may be required to explore this phenomenon in order to develop additional strategies for managing fulminate hepatic failure induced by Wilson's disease, as most conventional medications typically reduce triglyceride levels in cases of acute hepatic failure, except omega-3, insulin, and heparin infusions. However, there is no standard guideline for such.
In this case, despite lacking other signs such as Kayser-Fleischer rings, 24-hour urinary copper, liver copper level, or multiple mutations in the ATP7B gene, having a ceruloplasmin level lower than 10 mg/dL showed a high level of specificity (100%) and positive predictive value (100%) in the scoring system for diagnosing Wilson's disease. Further investigations can yield a conclusive diagnosis, which was limited in this case due to the patient's decision to leave against medical advice. However, based on this article, the main idea conveyed is the importance of adopting a broad approach to acute hepatitis [6]. Implementing this practice would lead to significant benefits for the patient and contribute to the reduction of preventable complications associated with cirrhosis in the long term [7].
Conclusions
It is not justified to attribute acute hepatitis with markedly elevated liver enzymes solely to a history of extensive alcoholism. Instead, it would be beneficial to investigate other potential causes, such as Wilson's disease and hemochromatosis. By doing so, we can intervene in the entire pathological process, improve the outcome dramatically, and prevent avoidable complications in cirrhosis.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Handbook of clinical neurology Pediatric Neurology Part III Kaler SG 17451754 Amsterdam, Netherlands Elsevier B.V.113201310.1016/B 978-0-444-59565-2.00045-9PMC 421486423622398 · doi ↗ · pubmed ↗
- 2Handbook of clinical neurology Wilson Disease Boga S Ala A Schilsky ML 9199 Amsterdam, Netherlands Elsevier B.V.142201710.1016/B 978-0-444-63625-6.00009-428433114 · doi ↗ · pubmed ↗
- 3Liver enzyme alteration: a guide for clinicians Can Med Assoc Giannini EG Testa R Savarino V 367379172200510.1503/cmaj.1040752 PMC 54576215684121 · doi ↗ · pubmed ↗
- 4Abnormal liver enzymes: a review for clinicians World J Hepatol Kalas MA Chavez L Leon M Taweesedt PT Surani S 168816981320213490403810.4254/wjh.v 13.i 11.1688 PMC 8637680 · doi ↗ · pubmed ↗
- 5Wilson's disease and iron overload: pathophysiology and therapeutic implications Clin Liver Dis (Hoboken) Pak K Ordway S Sadowski B Canevari M Torres D 61661720213368043710.1002/cld.986PMC 7916432 · doi ↗ · pubmed ↗
- 6Diagnostic accuracy of serum ceruloplasmin in Wilson disease: determination of sensitivity and specificity by ROC curve analysis among ATP 7B-genotyped subjects Clin Chem Mak CM Lam CW Tam S 135613625420081855633310.1373/clinchem.2008.103432 · doi ↗ · pubmed ↗
- 7Cirrhosis and coagulopathy: mechanisms of hemostasis changes in liver failure and their management Cureus Islam R Kundu S Jha SB 014202210.7759/cureus.23785 PMC 906373135518552 · doi ↗ · pubmed ↗
